MannKind Corp (NAS:MNKD)
$ 6.61 -0.06 (-0.9%) Market Cap: 1.84 Bil Enterprise Value: 1.83 Bil PE Ratio: 83.38 PB Ratio: 0 GF Score: 74/100

MannKind Corp at Cantor Fitzgerald Global Healthcare Conference Transcript

Sep 27, 2023 / 03:30PM GMT
Release Date Price: $4.1 (+1.74%)
Olivia Bryer
Cantor Fitzgerald - Analyst

Welcome to day two of our Cantor Healthcare Conference. Really excited to be back in person with everyone this year. My name is Olivia Bryer, I'm a senior biotech analyst here at Cantor. And really excited to have our guest speaker with us here today. We've got CEO of MannKind, Michael Castagna. Michael, thanks so much for joining us today.

Michael Castagna
MannKind Corporation - CEO

Thank you.

Olivia Bryer
Cantor Fitzgerald - Analyst

Yeah. Great to see you.

Michael Castagna
MannKind Corporation - CEO

Thanks for having us.

Questions & Answers

Olivia Bryer
Cantor Fitzgerald - Analyst

Michael, I'm sure most of the room is familiar with the story, and you guys obviously have a lot going on. I think the story is going through a significant transition right now with the company. So maybe just to kick things off, set the stage with where the company is today, some of the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot